NDAs SHOULD CONTAIN NARRATIVE DESCRIPTIONS OF DEATHS AND SERIOUS ADVERSE EVENTS OCCURRING IN CLINICAL TRIALS, FDA's GUIDELINE FOR CLINICAL DATA IN AN NDA SAYS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".